Home >> Science >> Physics >> Medical Physics >> BNCT




Boron neutron capture therapy (BNCT) occurs as form of radiosurgery that utilizes the neutron beam that interacts with boron injected to a patient. BCNT depends on the interaction of slow neutrons sustaining boron-10 to create alpha particles, an additional nature and severity of radiation. Patients come number 1 given an endovenous injection of the boron-10 tagged chemical substance that preferentially binds tumour cells. the neutrons come created either within a nuclear reactor or by colliding high-energy protons into a Atomic number 3 target. a neutrons pass across a moderator, which shapes the neutron energy spectrum suitable for BNCT professional assistance. Prior to typing the patient a neutron beam is shaped by a beam collimator. When passing through a tissue of the patient, the neutrons come slowed by collisions & be moo energy thermal neutrons. A thermal neutrons undergo reaction sustaining a boron-10 nuclei, forming an unstable boron-11 nucleus which so undergoes self-generated decompose to lithium-7 & an alpha particle. Two the alpha particle & a li ion make closely separated ionizations in the quick neck of the woods of the reaction, using a range of or even so Ten micrometres, or of these cell across. This system is appropriate since the radiation damage occurs across a short range & so normal tissues may be spared. Too, there are 2 mechanisms for tumour selectivity, since two a b compound is mass produced to attach to neoplasm cells & a neutron beam is aimed at a location of the tumour. BNCT has been developed around exclusively within an experimental basis, & it has non entered surgical routine.

Links
[http://www.vtt.fi/pro/pro1/bnct/index.htm Helsinki University Central Hospital and Technical Research Centre of Finland BNCT Project]

The Basics of Boron Neutron Capture Therapy (BNCT)
Clinical trials of BNCT are ongoing at the MIT Nuclear Reactor Laboratory. Scientific paper with citations, diagrams and photographs.

BNCT Program at Harvard / MIT for GBM and Melanoma
Joint site for the project by CareGroup, Beth Israel Deaconess Medical Center, Harvard Medical School Nuclear Reactor Laboratory, and Massachusetts Institute of Technology.






© 2005 GeneralAnswers.org